Purification and concentration of non-infectious West Nile virus-like particles and infectious virions using a pseudo-affinity Cellufine Sulfate column (Q43035493)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 1, 2011

Language	Label	Description	Also known as
English	Purification and concentration of non-infectious West Nile virus-like particles and infectious virions using a pseudo-affinity Cellufine Sulfate column	scientific article published on April 1, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Purification and concentration of non-infectious West Nile virus-like particles and infectious virions using a pseudo-affinity Cellufine Sulfate column (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

West Nile virus

0 references

1 reference

based on heuristic

inferred from title

Tetsutarō Sata

9

object named as

Tetsutaro Sata

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

8

object named as

Takeshi Kurata

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Naohiro Ohtaki

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hidehiro Takahashi

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Keiko Kaneko

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yasuyuki Gomi

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Toyokazu Ishikawa

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yasushi Higashi

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Masami Todokoro

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Asato Kojima

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21440004

28 November 2024

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0166093411001121?httpAccept=text/xml

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

https://api.elsevier.com/content/article/PII:S0166093411001121?httpAccept=text/plain

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Journal of Virological Methods

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

174

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

131-135

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

1

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

An Hsp60 related protein is associated with purified HIV and SIV.

2

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

3

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

West Nile virus: recent trends in diagnosis and vaccine development

4

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity

5

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

N-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and Infectivity

6

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis

7

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses

8

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine

9

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

A live, attenuated recombinant West Nile virus vaccine

10

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains)

11

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate

12

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Virus harvesting and affinity-based liquid chromatography. A method for virus concentration and purification

13

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles.

14

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.

15

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions

16

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Highly sulfated forms of heparin sulfate are involved in japanese encephalitis virus infection.

17

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Development of Vero cell-derived inactivated Japanese encephalitis vaccine

18

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus

19

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Long-term stability of Vero cell-derived inactivated Japanese encephalitis vaccine prepared using serum-free medium

20

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system.

21

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Sulfated Polysaccharides Extracted from Sea Algae as Potential Antiviral Drugs

22

1 reference

10.1016/J.JVIROMET.2011.03.021

https://api.crossref.org/works/10.1016/J.JVIROMET.2011.03.021

28 November 2024

Identifiers

10.1016/J.JVIROMET.2011.03.021

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43035493&oldid=2280682156"